Patients Challenging conventional wisdom on injectables, with Mehul D... Mehul Desai, VP of medical affairs at Enable Injections, sat down with pharmaphorum editor-in-chief Jonah Comstock at AAPS.
Events Partner Content 15th Annual Pre-Filled Syringes and Injectable Drug Devices ... The Future of Drug Delivery and Combination Products
Partner Content Partner Content Chairs post an invitation letter for the 12th Annual Pre-Fil... Chairs post an invitation letter for the 12th Annual Pr
Partner Content Partner Content Only four weeks left until the 2nd Injectable Drug Delivery ... The 2019 agenda features a global panel of speakers
Partner Content Partner Content Exclusive speaker interviews with Merck and Sanofi - Injecta... SMi’s Injectable Drug Delivery Conference
Partner Content Partner Content Conference Chair from MedinCell invites you to attend Inject... Injectable Drug Delivery Conference
News Dupixent is first FDA-approved drug for rare skin disease The long list of therapeutic uses for Sanofi and Regeneron's Dupixent has been lengthened by an FDA approval for rare skin disease bullous pemphigoid.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
